# Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)

> **NCT06077149** · PHASE4 · COMPLETED · sponsor: **University of Rochester** · enrollment: 152 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** RSV vaccine

## Key facts

- **NCT ID:** NCT06077149
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-07
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2025-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06077149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06077149, "Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06077149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*